CRON's Quality Score rose 1 point on Mon, Nov 2, to 16. Its high and its low were both higher than the day before.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Up 35% in a year while the S&P 500 rose 12%.
“The increase was primarily due to higher average sales prices, largely driven by a mix shift to Israel and other countries”
| Gross margin | Up 13.1 points on the year |
| Latest filing | 8-K, Oct 15 |
ReportReports Thursday, before the open. Every 3 months, a company tells everyone how much it sold and earned. It rose after 3 of its last 4 reports, +4.6% on average. Past reports ›
After its last 4 reports it closed +4.6% on average, higher 3 of 4 times.
Excellentfor quality, not price, 6 of 14 chart checks firingWhat the Quality Score means
CRON is #5 of 92 by Quality Score.
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 5 |
Net income over four quarters: CRON $70.0M, TLRY -$164M.
Reports Thu Nov 5, before the open (in 3 days). Confirmed.
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
The figures are not read from the release yet.
“The increase was primarily due to higher cannabis flower sales in Israel and other countries, specifically Germany, which carry no excise taxes, and higher cannabis flower and extract sales in the Canadian market.”
CRON's results filing gives no sales by line in a table we read. Its annual report gives the year's, in About.
No outlook figures read from this release.
“The increase was primarily due to higher average sales prices, largely driven by a mix shift to Israel and other countries, which carry no excise taxes, and higher sales volumes.”
From its results filing (SEC filing · Aug 6)
Sales grew 19% a year over 3 years, fiscal 2022 to 2025.
Its share count grew 1.8% a year over 5 years.
| Reported | Gap | Reaction | 5 sessions |
|---|---|---|---|
| Aug 6, 2026 | +11.0% | +12.9% | +16.5% |
| May 11, 2026 | +9.4% | +8.3% | +3.5% |
| Feb 26, 2026 | -3.6% | -3.6% | -5.4% |
Sales grew every year from 2018 to 2025, to $147M. It lost money in 2025 after a profit in 2024.
Officers and directors with a Form 4 in the last 12 months.
Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.
“The Company faces competition in all aspects of its business in the Canadian adult-use and medical markets.”
CRON scores 16 today, which Breakaway calls Excellent. It is #5 of 92 in Pharma by Quality Score, with 6 of 14 chart checks firing. Up 35% in a year while the S&P 500 rose 12%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
CRON scores 16 today, which Breakaway calls Excellent (15 to 19). That is #5 of 92 in Pharma by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind CRON's 16.
Reports Thu Nov 5, before the open, a date the company confirmed. CRON closed higher after 3 of its last 4 reports. Past behavior, not a forecast.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.